Back to top

Galmed Pharmaceuticals (GLMD) in Focus: Stock Moves 6.2% Higher

Read MoreHide Full Article

Galmed Pharmaceuticals Ltd. (GLMD - Free Report) ) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $8.47 –$11.38 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen three positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Galmed Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Galmed Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Investors interested in the Medical - Drugs industry may consider a better-ranked stock like BioSpecifics Technologies Corp (BSTC - Free Report) , which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is GLMD going up? Or down? Predict to see what others think:Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


BioSpecifics Technologies Corp (BSTC) - free report >>

Galmed Pharmaceuticals Ltd. (GLMD) - free report >>